Skip to search formSkip to main contentSkip to account menu

EGYT 475

Known as: EGYT-475 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Piperazines

Narrower (1)

Trelibet

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
Studies on the biochemical mode of action of EGYT-475, a new antidepressant.
We studied the mode of action of N-benzyl-piperazine-picolinylfumarate (EGYT-475) and of its metabolite N-benzyl-piperazine (EGYT… 
1987
1987
The effect of EGYT-475 (Trelibet) and its metabolites on the potassium-stimulated 3H-noradrenaline release from cortical slices of rat brain.
The effect of a new antidepressant drug: EGYT-475 (Trelibet) and its metabolites: EGYT-1354 and EGYT-2760 on the K+-stimulated… 
1987
1987
PHARMACOKINETIC ASPECTS OF THE MODE OF ACTION OF EGYT-475, A NEW ANTIDEPRESSIVE AGENT
1987
1987
Computer analysis of the pharmacokinetic parameters of EGYT-475, a new antidepressant agent.
A successful application of an Apple II microcomputer in determining pharmacokinetic parameters from on-line data is described. 
1987
1987
The metabolism of EGYT-475, a new antidepressant agent, in rats.
The metabolites of EGYT-475 excreted by the kidney were studied in rats using radioactive analogues of the compound tested. 40… 
1987
1987
Pharmacokinetic aspects of the mode of action of EGYT-475, a new antidepressant agent.
EGYT-475 (N-benzyl-piperazine-picolinyl fumarate; Trelibet) metabolism was compared in rats, dogs and man. In the rat 7 urinary… 
1983
1983
Effects of a new antidepressant drug on active avoidance behavior in rats. Comparative study with tricyclic antidepressants.
The effects of a new antidepressant drug, EGYT-475 (1-benzyl-4-(2'-pyridylcarbonyl)-piperazine) on the acquisition and extinction… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)